Historial del iniciado Otro Rendimiento medio T+90
+2.8%
Sobre 13 señales de compra con un rendimiento T+90 consolidado. Base de rendimiento: cierre del día siguiente a la publicación.
Explore the complete record of transactions filed by Luke Miels. Officer active across 1 company, notably GSK plc. Cumulatively, 58 disclosures have been published. History available since 12 October 2023. The latest transaction was disclosed on 10 July 2026 (Vesting). Regulator: RNS (LSE). The full history is accessible without signup.
Companies and markets linked to Luke Miels Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declaraciones 58 en total
● Chief Executive Officer · Directivos · 9 jul 2026 · GSK plc 0
London Stock Exchange (XLON)ISIN ISIN GB00BN7SWP63RNS:9668630-0 ● Chief Executive Officer · Directivos · 10 jul 2026 · GSK plc 1241 títulos @ 19,595 GBP 0.0032% mcap 0.1% de su flujo London Stock Exchange (XLON)ISIN ISIN GB00BN7SWP63RNS:9668630-15 ● Chief Executive Officer · Directivos · 9 jul 2026 · GSK plc 0
London Stock Exchange (XLON)ISIN ISIN GB00BN7SWP63RNS:0920c70b-f075-4c99-aba0-46720a29730a-0 ● Chief Executive Officer · Directivos · 9 jul 2026 · GSK plc 3 títulos @ 19,63 GBP 0.0000% mcap 0.0% de su flujo London Stock Exchange (XLON)ISIN ISIN GB00BN7SWP63RNS:9666294-9 ● Chief Executive Officer · Directivos · 9 jul 2026 · GSK plc 3 títulos @ 19,63 GBP 0.0000% mcap 0.0% de su flujo London Stock Exchange (XLON)ISIN ISIN GB00BN7SWP63RNS:06e0a094-373b-4460-b97c-91525b0dd5d9-9 ● Chief Executive Officer · Directivos · 14 abr 2026 · GSK plc 1178 títulos @ 21,67 GBP 0.0000% mcap 0.1% de su flujo London Stock Exchange (XLON)ISIN ISIN GB00BN7SWP63RNS:ca89baf1-aabf-4020-b0fe-d5c65c1b3a57-0 ● Chief Executive Officer · Directivos · 9 abr 2026 · GSK plc 0
London Stock Exchange (XLON)ISIN ISIN GB00BN7SWP63RNS:66208821-3d67-43ba-837e-411f45d449f1-4 ● Chief Executive Officer · Directivos · 9 abr 2026 · GSK plc 2 títulos @ 21,34 GBP 0.0000% mcap 0.0% de su flujo London Stock Exchange (XLON)ISIN ISIN GB00BN7SWP63RNS:5b5d692c-e307-4a46-a436-f5464b4ee34b-0 ● Chief Executive Officer · Directivos · 13 feb 2026 · GSK plc 245.716 títulos 0
N/AISIN ISIN GB00BN7SWP63RNS:9e068048-67e6-4a53-8636-ebe7180e6da4-0 ● Chief Executive Officer · Directivos · 13 feb 2026 · GSK plc 15.579 títulos @ 21,6002 GBP 1.5% de su flujo London Stock Exchange (XLON)ISIN ISIN GB00BN7SWP63RNS:9e068048-67e6-4a53-8636-ebe7180e6da4-1 ● Chief Executive Officer · Directivos · 12 feb 2026 · GSK plc 27.962 títulos @ 21,50 GBP 2.7% de su flujo N/AISIN ISIN GB00BN7SWP63RNS:6207777f-2477-470b-868f-21f92714189a-0 ● Chief Executive Officer · Directivos · 12 feb 2026 · GSK plc 463.662 títulos @ 21,50 GBP 44.5% de su flujo N/AISIN ISIN GB00BN7SWP63RNS:586c5c74-54b9-425a-a37c-ba21836ecce7-0 ● Chief Executive Officer · Directivos · 9 feb 2026 · GSK plc 4549 títulos @ 22,114 GBP 0.5% de su flujo London Stock Exchange (XLON)ISIN ISIN GB00BN7SWP63RNS:527591f3-f598-44b4-87bb-f5cfd91a36cb-1 ● Chief Executive Officer · Directivos · 9 feb 2026 · GSK plc 60.334 títulos 0
N/AISIN ISIN GB00BN7SWP63RNS:527591f3-f598-44b4-87bb-f5cfd91a36cb-0 ● Chief Executive Officer · Directivos · 10 feb 2026 · GSK plc 0
N/AISIN ISIN GB00BN7SWP63RNS:8df504c6-f415-410b-a190-e5ddcfc0debe-0 ● Chief Executive Officer · Directivos · 8 ene 2026 · GSK plc 3 títulos @ 18,9433 GBP 0.0% de su flujo London Stock Exchange (XLON)ISIN ISIN GB00BN7SWP63RNS:07b8fade-09b6-4441-a582-c78ac4e1b6b3-0 ● Chief Executive Officer · Directivos · 9 ene 2026 · GSK plc 1462 títulos @ 18,91 GBP 0.1% de su flujo London Stock Exchange (XLON)ISIN ISIN GB00BN7SWP63RNS:07b8fade-09b6-4441-a582-c78ac4e1b6b3-24 ● Chief Commercial Officer · Directivos · 10 oct 2025 · GSK plc 1670 títulos @ 16,40 GBP 0.2% de su flujo London Stock Exchange (XLON)ISIN ISIN GB00BN7SWP63RNS:5862277-5 ● Chief Commercial Officer · Directivos · 9 oct 2025 · GSK plc 3 títulos @ 16,3933 GBP 0.0% de su flujo London Stock Exchange (XLON)ISIN ISIN GB00BN7SWP63RNS:5859068-4 ● Chief Commercial Officer · Directivos · 10 jul 2025 · GSK plc 3 títulos @ 14,4433 GBP 0.0% de su flujo London Stock Exchange (XLON)ISIN ISIN GB00BN7SWP63RNS:5737340-13 ● Chief Commercial Officer · Directivos · 10 jul 2025 · GSK plc 1862 títulos @ 14,545 GBP 0.2% de su flujo London Stock Exchange (XLON)ISIN ISIN GB00BN7SWP63RNS:5737340-24 ● Chief Commercial Officer · Directivos · 16 abr 2025 · GSK plc 2098 títulos @ 12,75 GBP 0.2% de su flujo London Stock Exchange (XLON)ISIN ISIN GB00BN7SWP63RNS:5622701-5 ● Chief Commercial Officer · Directivos · 10 abr 2025 · GSK plc 0
London Stock Exchange (XLON)ISIN ISIN GB00BN7SWP63RNS:5617047-13 ● Chief Commercial Officer · Directivos · 10 abr 2025 · GSK plc 3 títulos @ 13,1267 GBP 0.0% de su flujo London Stock Exchange (XLON)ISIN ISIN GB00BN7SWP63RNS:5615070-13 ● Chief Commercial Officer · Directivos · 17 feb 2025 · GSK plc 298.713 títulos @ 14,35 GBP 39.7% de su flujo N/AISIN ISIN GB00BN7SWP63RNS:5546836-5 25 de 58 declaraciones
Ver más (33 restantes) About Luke Miels Luke Miels is Chief Executive Officer at GSK plc. He has 55 filings in total, and across the 55 sampled filings between 2023-10-13 and 2026-07-14, the aggregated amounts show EUR 708 of buys and EUR 1304780 of sells.